ArticleScientific reports2025
Expression of phosphohistone H3 and X-linked inhibitors of apoptosis-related proteins in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary glands.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The two most prevalent cancers of the salivary glands are adenoid cystic carcinoma (AdCC) and mucoepidermoid carcinoma (MEC). They show great variation in clinical presentation and histopathological features, which can influence patient prognosis. Phosphohistone H3 (PHH3) is an essential histone protein involved in chromatin structure and cell division. It has proven valuable in diagnosing and grading several tumor types. X-linked inhibitor of apoptosis protein (XIAP) prevents apoptosis. Both PHH3 and XIAP could shed light on the biological behavior prognosis of MECs and AdCCs. The purpose of this research was to assess the expression of PHH3 and XIAP in different histological types of MEC and AdCC and examine their relationships with the clinicopathological characteristics of patients. This study analyzed 30 archived paraffin-embedded tissue blocks, including 16 samples from MEC patients and 14 from AdCC patients. Immunohistochemical staining was performed to assess PHH3 and XIAP expression. The results were evaluated via a semiquantitative scoring system and statistically correlated with clinicopathological characteristics. All patients had positive immunohistochemical expression of both PHH3 and XIAP. Higher levels of these markers were directly associated with higher histological grades in both MECs and AdCCs. PHH3 and XIAP expression strongly correlated with each other. Immunoreactivity for both markers was significantly elevated in tumors with higher-grade histopathological features. The histological grade of MEC and AdCC might be affected by the expression of PHH3 and XIAP biomarkers. However, further studies with larger sample sizes are needed to confirm the possible prognostic role of PHH3 and XIAP in the diagnosis of MEC and AdCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.